Diagnosis and Treatment of Infections due to<i>Mycobacterium avium</i>Complex

Kasperbauer, Shannon; Daley, Charles L.

doi:10.1055/s-0028-1085708

Cited by 73 publications

(54 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…paratuberculosis). 99 The rapid-growing NTM species include those in the M. abscessus complex. Although the taxonomy of the M. abscessus complex was uncertain at the time of publication, currently 3 closely related subspecies are described: M. abscessus subsp.…”

Section: Ic5 Nontuberculous Mycobacteriamentioning

confidence: 99%

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Saiman

Siegel

LiPuma

et al. 2014

Infect. Control Hosp. Epidemiol.

352

382

View full text Add to dashboard Cite

The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1. The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2. Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.

show abstract

Section: Ic5 Nontuberculous Mycobacteriamentioning

confidence: 99%

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Saiman

Siegel

LiPuma

et al. 2014

Infect. Control Hosp. Epidemiol.

352

382

View full text Add to dashboard Cite

show abstract

“…Las drogas de primera línea incluyen macrólidos como la claritromicina, la azitromicina, el etambutol y rifampicinas como el rifabutin y la rifampicina. Los aminoglucósidos como la estreptomicina y la amikacina son utilizados en pacientes con lesiones cavitarias (14) . En nuestro caso, el paciente fue tratado con una combinación de cuatro drogas que incluían etambutol, rifampicina, claritromicina y amikacina ya que presentaba una lesión cavitaria en el pulmón.…”

Section: Discussionunclassified

Infección pulmonar por Mycobacterium avium en paciente VIH/SIDA: primer reporte en Perú

Carrasco

Soto

Samalvides

et al. 2014

Rev Peru Med Exp Salud Publica

View full text Add to dashboard Cite

RESUMENEl complejo Mycobacterium avium (MAC) es un patógeno que se encuentra en el medioambiente y causa infecciones tanto en pacientes inmunocompetentes como inmunocomprometidos. Se presenta el caso de un paciente VIH positivo varón de 38 años infectado por P. jirovecii y aparentemente infectado por Mycobacterium tuberculosis desde el año 2009, el cual fue tratado con antibioticoterapia para pneumocistosis y terapia antituberculosis (TB) logrando mejoría parcial. En el año 2012 se le realizó nuevamente examen de cultivo y un nuevo tratamiento anti TB, frente a la sospecha de estar en presencia de una cepa de TB multidrogorresistente se recomienda realizar la identificación micobacteriana. El examen de cultivo fue positivo y el resultado genotípico resultó positivo para MAC. Se reporta el primer caso de un paciente VIH/SIDA con infección pulmonar por MAC en el Perú, así como una breve revisión de los aspectos epidemiológicos, clínicos y de tratamiento. Palabras clave: Complejo Mycobacterium avium; Infecciones por VIH; Infecciones del sistema respiratorio (fuente: DeCS BIREME) Mycobacterium avium LUNG INFECTION IN HIV/AIDS PATIENT: FIRST REPORT IN PERU ABSTRACTThe Mycobacterium avium complex (MAC) is a pathogen found in the environment which causes infections in immunocompetent and immunocompromised patients. One case is presented: an HIV positive, 38 year old male patient, infected with P. jirovecii and apparently infected with Mycobacterium tuberculosis since 2009. He was treated with antibiotic therapy for pneumocystosis and antituberculosis (TB) therapy, which achieved a partial improvement. In 2012, the patient underwent a culture test and new anti TB treatment. Upon suspicion of a drug resistant TB strain, it was recommended to perform the mycobacterial identification. The culture test was positive and the genotypic result was positive for MAC. The first case of an HIV/AIDS patient with MAC lung infection in Peru is reported, as well as a brief review of the epidemiological, clinical and treatment aspects to the case.

show abstract

“…paratuberculosis in food Cirone et al, 2007 Mycobacterium avium subsp. paratuberculosis in milk and cheese Grant, 2006 Emerging bacterial pathogens in meat and poultry Mor-Mur and Yuste, 2010 Isolation of mycobacteria from porcine lymph nodes van Ingen et al, 2010 Mycobacterium avium from patients and foods Yoder et al, 1999 Infections due to Mycobacterium avium complex Kasperbauer and Daley, 2008;McGrath et al, 2010 Mycobacterium bovis as a zoonosis Thoen et al, 2006 Tuberculosis: a re-emerging disease in animals and humans Thoen et al, 2009 Nontuberculous mycobacteria causing disease in humans van Ingen et al, 2009 Mycobacteria and HIV-Infected Individuals Yajko et al, 1995 Free-living amoebae -a vector for mycobacteria Salah et al, 2009 Mycobacteria in water and biofilms Falkinham 2009a,b;Falkinham, 2010 …”

Section: Methodsmentioning

confidence: 99%

Mycobacteria in water, feedstocks and food: analysis of publications

Kaevska¹,

Hruška²

2010

Vet. Med.

View full text Add to dashboard Cite

Papers on mycobacteria in food, feed and water, published between 1945 and 2010 and indexed in the database Web of Science ® (Thomson Reuters) were ranked according to authors, institutions, countries and source titles. The total number of papers on mycobacteria and food and mycobacteria and water were 1486 and 1419, respectively. More than 40% of papers have been published in the last five years. In addition to publications in peer reviewed journals the archives of ProMED-mail and the Rapid Alert System for Food and Feed of the European Union were also searched. It is evident that much attention is being paid to mycobacteria in food, feed and water as they likely pose a public health risk.

show abstract

Diagnosis and Treatment of Infections due toMycobacterium aviumComplex

Cited by 73 publications

References 39 publications

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

Infección pulmonar por Mycobacterium avium en paciente VIH/SIDA: primer reporte en Perú

Mycobacteria in water, feedstocks and food: analysis of publications

Contact Info

Product

Resources

About